Meeting Report

New Directions in Acute Myeloid Leukemia

Presented by Kelda Gardner, PA-C, MHS, and Melinda Tran, PharmD, BCOP

University of Washington, Seattle, Washington; and YouScript, Inc., and the University of Washington, Seattle, Washington

Presenters’ disclosures of conflicts of interest are found at the end of this article.


J Adv Pract Oncol 2019;10(3):299–303 | https://doi.org/10.6004/jadpro.2019.10.3.18 | © 2019 Harborside™


  

ABSTRACT

Acute myeloid leukemia (AML) is diagnosed in about 20,000 people a year and remains a very challenging malignancy to treat. Kelda Gardner, PA-C, MHS, and Melinda Tran, PharmD, BCOP, reviewed the basics of treating AML, including new assessment approaches, treating hematologic emergencies, and the safety and efficacy of novel agents.




For access to the full length article, please sign in.

Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2010-2019 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.